Annovis Bio (ANVS) Earnings Analysis

Annovis Bio (ANVS) next reports earnings on 2026-08-11, consensus EPS -0.44 USD. Last quarter (2026-05-15) it missed with EPS -0.63 USD vs -0.395 USD est (-59.5%). It has beaten estimates in 1/5 recent quarters (20%). Trailing P/E -1.01.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does ANVS next report earnings?

Next earnings date2026-08-11
Consensus EPS estimate-0.44 USD
Revenue estimaten/a

ANVS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-15-0.63 USD-0.395 USD-59.5%Miss
2026-03-16-0.39 USD-0.3084 USD-26.5%Miss
2025-03-21-0.43 USD-0.38 USD-13.2%Miss
2024-11-08-0.97 USD-0.53 USD-83%Miss
2024-08-14-0.44 USD-0.63 USD+30.2%Beat

Beat rate: 1/5 (20%) over reported quarters with consensus data.

ANVS valuation and analyst view

Trailing P/E-1.01
Trailing EPS-1.46953 USD
Price / book15.50
Dividend yield0.00%
Market cap0.03B
Analyst consensusBuy (6 buy / 2 hold / 0 sell)

Related research pages

Frequently asked questions

When is Annovis Bio (ANVS)'s next earnings date?

Annovis Bio is next scheduled to report on 2026-08-11, with a consensus EPS estimate of -0.44 USD.

Did ANVS beat earnings last quarter?

In its 2026-05-15 report, ANVS posted EPS of -0.63 USD versus a -0.395 USD estimate — a miss of 59.5%.

What is ANVS's earnings track record?

Over the last 5 reported quarters with consensus data, ANVS beat estimates 1 times (20%).

What is ANVS's current P/E ratio and EPS?

ANVS trades at a trailing P/E of -1.01 on trailing EPS of -1.4695313846595806 USD.

What do analysts rate ANVS?

Analyst consensus is "Buy" across 8 ratings (0 strong buy, 6 buy, 2 hold, 0 sell, 0 strong sell).